The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Starting with the launch of the Human Genome Project in 1990, the past quarter-century has brought spectacular achievements in genomics that dramatically empower the study of human biology and disease. The human genomics enterprise is now in the midst of an important transition, as the growing foundation of genomic knowledge is being used by researchers and clinicians to tackle increasingly complex...
As the average life expectancy increases, particularly in developing countries, prevalence of neurodegenerative diseases has also increased. This trend is especially alarming for Alzheimer's disease (AD); as there is no cure to stop or reverse the effects of AD. However, recent pharmacological advances can slow the progression of AD, but only if AD is diagnosed at early stages. We have previously...
As the average age of our population increases, the prevalence of Alzheimer's Disease (AD), the most common form of dementia, has grown sharply. Current diagnosis of AD primarily uses longitudinal clinical evaluations and/or invasive lumbar punctures for CSF analysis, available only at specialized hospitals, which are generally outside of financial and geographical reach of most patients. We expand...
As a natural consequence of steady increase of average population age in developed countries, Alzheimer's disease is becoming an increasingly important public health concern. The financial and emotional toll of the disease is exacerbated with lack of standard diagnostic procedures available at the community clinics and hospitals, where most patients are evaluated. In our recent preliminary results,...
The diagnosis of Alzheimer's disease (AD) at an early stage is a major concern due to growing number of elderly population affected by the disease, as well as the lack of a standard diagnosis procedure available to community clinics. Recent studies have used wavelets and other signal processing methods to analyze EEG signals in an attempt to find a non-invasive biomarker for AD. These studies had...
With the rapid increase in the population of elderly individuals affected by Alzheimer's disease, the need for an accurate, inexpensive and non-intrusive diagnostic biomarker that can be made available to community healthcare providers presents itself as a major public health concern. The feasibility of EEG as such a biomarker has gained a renewed attention as several recent studies, including our...
With the number of the elderly population affected by Alzheimer's disease (AD) rising, the need to find an accurate, inexpensive and non-intrusive procedure that can be made available to community healthcare providers for early diagnosis of Alzheimer's disease is becoming more and more urgent as a major health concern. Several recent studies have looked at analyzing electroencephalogram signals through...
We describe an ensemble of classifiers based data fusion approach to combine information from two sources, believed to contain complimentary information, for early diagnosis of Alzheimer's disease. Specifically, we use the event related potentials recorded from the Pz and Cz electrodes of the EEG, which are further analyzed using multiresolution wavelet analysis. The proposed data fusion approach...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.